Study on the Development of a Conceptual Framework to Identify the Risk Factors of Diabetic Retinopathy Among Diabetic Patients: A Concept Paper

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Oct 14

PMID 36231721

Authors

Nurul Athirah Naserrudin

Mohammad Saffree Jeffree

Nirmal Kaur

Syed Sharizman Syed Abdul Rahim

Mohd Yusof Ibrahim

Affiliations

Soon will be listed here.

Abstract

The most common complication of diabetes mellitus (DM) is diabetic retinopathy (DR). The control of DR risk factors is essential for the effective prevention of DR. There is currently a lack of research to guide DR-related research in Malaysia. This concept paper aimed to review published studies and propose a conceptual framework (CF) as a guide for future research to determine the prevalence of DR and its risk factors across DM patients. After a review of prior research, this study has presented a CF that takes into account these four key elements: the patient's sociodemographic characteristics, comorbidities, complications, and diabetes conditions, namely, the length of the disease and glycaemic control. In the suggested CF, ethnicity was highlighted as a crucial risk factor for DR across lower- to middle-income countries (LMIC) and multiracial countries. In order to guide future studies, scientific guidance is essential. The proposed CF would help future research to conduct scientific research related to DR. Also, the proposed CF was tailored to suit research across LMIC and multiracial countries.

References

van Leiden H, Dekker J, Moll A, Nijpels G, Heine R, Bouter L . Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. 2002; 25(8):1320-5. DOI: 10.2337/diacare.25.8.1320. View

Ting D, Cheung G, Wong T . Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2015; 44(4):260-77. DOI: 10.1111/ceo.12696. View

Lima V, Cavalieri G, Lima M, Nazario N, Lima G . Risk factors for diabetic retinopathy: a case-control study. Int J Retina Vitreous. 2016; 2:21. PMC: 5088444. DOI: 10.1186/s40942-016-0047-6. View

Chawla A, Chawla R, Jaggi S . Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocrinol Metab. 2016; 20(4):546-51. PMC: 4911847. DOI: 10.4103/2230-8210.183480. View

Dew A . Protocol Paper: Conducting Life History Interviews to Explore the Journeys of People with Disability from Syrian and Iraqi Refugee Backgrounds Settling in Australia. Int J Environ Res Public Health. 2021; 18(15). PMC: 8345357. DOI: 10.3390/ijerph18157978. View

Wong T, Cheung N, Tay W, Wang J, Aung T, Saw S . Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008; 115(11):1869-75. DOI: 10.1016/j.ophtha.2008.05.014. View

Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong T . Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci. 2011; 52(7):4416-21. DOI: 10.1167/iovs.11-7208. View

Chang L, Lee A, Sue W . Prevalence of diabetic retinopathy at first presentation to the retinal screening service in the greater Wellington region of New Zealand 2006-2015, and implications for models of retinal screening. N Z Med J. 2017; 130(1450):78-88. View

Chang Y, Wu W . Dyslipidemia and diabetic retinopathy. Rev Diabet Stud. 2014; 10(2-3):121-32. PMC: 4063092. DOI: 10.1900/RDS.2013.10.121. View

10.

Klein R, Knudtson M, Lee K, Gangnon R, Klein B . The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008; 115(11):1859-68. PMC: 2761813. DOI: 10.1016/j.ophtha.2008.08.023. View

11.

Lopez M, Cos F, Alvarez-Guisasola F, Fuster E . Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study. J Clin Transl Endocrinol. 2017; 9:61-65. PMC: 5651300. DOI: 10.1016/j.jcte.2017.07.004. View

12.

Petrie J, Guzik T, Touyz R . Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584. PMC: 5953551. DOI: 10.1016/j.cjca.2017.12.005. View

13.

Phulkerd S, Rachmi C, Sameeha M, Borazon E, Thow A, Trevena H . Identifying Opportunities for Strategic Policy Design to Address the Double Burden of Malnutrition through Healthier Retail Food: Protocol for South East Asia Obesogenic Food Environment (SEAOFE) Study. Int J Environ Res Public Health. 2022; 19(1). PMC: 8744775. DOI: 10.3390/ijerph19010528. View

14.

Cuevas-Lara C, Izquierdo M, Zambom-Ferraresi F, Saez de Asteasu M, Marin-Epelde I, Chenhuichen C . A Feasibility Study for Implementation "Health Arcade": A Study Protocol for Prototype of Multidomain Intervention Based on Gamification Technologies in Acutely Hospitalized Older Patients. Int J Environ Res Public Health. 2020; 17(21). PMC: 7662354. DOI: 10.3390/ijerph17218058. View

15.

Gunnlaugsdottir E, Halldorsdottir S, Klein R, Eiriksdottir G, Klein B, Benediktsson R . Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R). Diabetologia. 2011; 55(3):671-80. PMC: 3269506. DOI: 10.1007/s00125-011-2395-y. View

16.

De Allegri M, Srivastava S, Strupat C, Brenner S, Parmar D, Parisi D . Mixed and Multi-Methods Protocol to Evaluate Implementation Processes and Early Effects of the Pradhan Mantri Jan Arogya Yojana Scheme in Seven Indian States. Int J Environ Res Public Health. 2020; 17(21). PMC: 7663328. DOI: 10.3390/ijerph17217812. View

17.

Diwan V, Purohit M, Chandran S, Parashar V, Shah H, Mahadik V . A Three-Year Follow-Up Study of Antibiotic and Metal Residues, Antibiotic Resistance and Resistance Genes, Focusing on Kshipra-A River Associated with Holy Religious Mass-Bathing in India: Protocol Paper. Int J Environ Res Public Health. 2017; 14(6). PMC: 5486260. DOI: 10.3390/ijerph14060574. View

18.

Hammer S, Busik J . The role of dyslipidemia in diabetic retinopathy. Vision Res. 2017; 139:228-236. PMC: 5702582. DOI: 10.1016/j.visres.2017.04.010. View

19.

Lee R, Wong T, Sabanayagam C . Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015; 2:17. PMC: 4657234. DOI: 10.1186/s40662-015-0026-2. View

20.

Kastelan S, Tomic M, Gverovic Antunica A, Ljubic S, Salopek Rabatic J, Karabatic M . Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm. 2013; 2013:436329. PMC: 3853039. DOI: 10.1155/2013/436329. View